The 2-Minute Rule for SITUS JUDI MBL77
Not all individuals with CLL demand therapy. Irrespective of all latest advances, the iwCLL continue to endorses watchful observation for individuals with asymptomatic disease.86 This advice relies on at least two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).Nikmati